TEGOYES 20/5.8/15.8MG CAPSULE

Form: Capsules

Pack Size: 7 CAPSULES

Marketed by: TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV)

MRP: ₹1300.30

TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV): Tegoyes 20/5.8/15.8MG Capsule, 7 capsules, salt tegafur + gimeracil + oteracil 20/5.8/15.8mg. NPPA has revised its MRP from Rs 3,064 to Rs 1,300.30 (58% lower) with effect from 09-11-2026; trade rate Rs 990.70. Group: oral fluoropyrimidine chemotherapy (S-1). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: not interchangeable with capecitabine dose for dose. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.